| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |